These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Delayed herpes zoster pseudodendrites. Polymerase chain reaction detection of viral DNA and a role for antiviral therapy. Pavan-Langston D, Yamamoto S, Dunkel EC. Arch Ophthalmol; 1995 Nov; 113(11):1381-5. PubMed ID: 7487598 [Abstract] [Full Text] [Related]
25. Prevalence of Ocular Manifestations and Visual Outcomes in Patients With Herpes Zoster Ophthalmicus. Szeto SK, Chan TC, Wong RL, Ng AL, Li EY, Jhanji V. Cornea; 2017 Mar; 36(3):338-342. PubMed ID: 27741018 [Abstract] [Full Text] [Related]
34. Physician survey for study of suppressive antiviral treatment to reduce chronic ocular disease and postherpetic neuralgia after herpes zoster ophthalmicus. Sackel DJ, Castano E, Cohen EJ. Eye Contact Lens; 2014 Jul; 40(4):200-6. PubMed ID: 24892787 [Abstract] [Full Text] [Related]
35. Incidence Rate of Herpes Zoster Ophthalmicus: A Retrospective Cohort Study from 1994 through 2018. Kong CL, Thompson RR, Porco TC, Kim E, Acharya NR. Ophthalmology; 2020 Mar; 127(3):324-330. PubMed ID: 31668889 [Abstract] [Full Text] [Related]
36. Clinical Profile of Herpes Zoster Ophthalmicus in a South Indian Patient Population. Babu K, Mahendradas P, Sudheer B, Kawali A, Parameswarappa DC, Pal V, Philips M. Ocul Immunol Inflamm; 2018 Mar; 26(2):178-183. PubMed ID: 29072860 [Abstract] [Full Text] [Related]
37. Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States. Lu A, Sun Y, Porco TC, Arnold BF, Acharya NR. Ophthalmology; 2021 Dec; 128(12):1699-1707. PubMed ID: 33892049 [Abstract] [Full Text] [Related]